TE_38966
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | LTR2B |
|---|---|
| TE superfamily | ERV1 |
| TE class | LTR |
| Gene | ENSG00000286201 |
| Class | Annoated |
| Coding | Non-coding |
| Tumor-specific score | 1.97 |
| Counts of samples | TCGA_tumor:524; TCGA_normal:99; GTEx:200 |
| TSS | chrY(-):16644343 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38966.1 | ENSG00000286201 | Annoated | Non-coding | Non-coding | chrY(-):16605823,16605843,16628538,16628580,16644044,16644344 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
